nav Searchuser
Maxunitech Inc.
Beijing Multigrass Formulation Co., Ltd.

Frontage Laboratories acquires Concord Biosciencesqrcode

Apr. 13, 2018

Favorites Print
Forward
Apr. 13, 2018
Frontage Laboratories Inc., a global CRO with headquarters in Exton, Pennsylvania, announces the acquisition of Concord Biosciences, formerly known as Ricerca Biosciences LLC, a preclinical CRO located near Cleveland, Ohio. Founded in 1986, Concord Bio supports the pharmaceutical, agricultural, chemical and animal health industries with Drug Safety, Metabolism, Bioanalytical, Residue and Environmental Fate studies.
 
Dr. Song Li, founder and CEO of Frontage Laboratories, said, "We have committed to build a global CRO company with integrated services. The acquisition of Concord Biosciences is a significant step toward reaching our goal. The addition of Concord Bio to the Frontage family will enable us to provide pharmaceutical product development services from lead selection to IND-enabling studies to commercialization. Additionally, the agrochemical expertise of Concord Bio will position Frontage as a major CRO in the agricultural products industry."
 
Source: PRNewswire

Picture 0/1200

More from AgroNews

Sichuan Lomon Bio Technology Co., Ltd.

Magazine

2019 Formulation & Adjuvant Technology Annual Review 2018
Chinese issue of Annual Review 2018 Chinese issue of 2018 Market Insight
2018 Market Insight Chinese issue of 2018 CRO & CRAO Manual
I wanna post a press Comment

Subscribe 

Subscribe Email: *
Name:
Mobile Number:  

Comment  

Picture 0/1200

Subscribe to daily email alerts of AgroNews.